1.9189
0.0089 (0.47%)
0.0089 (0.47%)
Upgrade to Real-Time
Regular Market
Low
0.78
High
4.56
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Citius Pharmaceuticals Inc | CTXR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0089 | 0.47% | 1.9189 | 12:12:40 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.88 | 1.86 | 2.00 | 1.91 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.91 | 1.92 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,041 | 1,506,844 | $ 1.93 | $ 2,913,878 | - | 0.78 - 4.56 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:12:49 | 50 | $ 1.9118 | USD |
Period:
Draw Mode:
Citius Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 280.27M | 145.98M | 133.67M | $ - | $ - | -0.46 | -5.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 9.10% |
Citius Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTXR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.90 | 2.10 | 1.81 | 1.95 | 3,502,353 | 0.0189 | 0.99% |
| 1 Month | 3.85 | 3.85 | 1.81 | 2.40 | 10,766,529 | -1.93 | -50.16% |
| 3 Months | 2.28 | 4.56 | 1.81 | 2.83 | 10,154,379 | -0.3611 | -15.84% |
| 6 Months | 1.30 | 4.56 | 1.16 | 2.27 | 13,354,963 | 0.6189 | 47.61% |
| 1 Year | 1.43 | 4.56 | 0.78 | 2.19 | 7,173,536 | 0.4889 | 34.19% |
| 3 Years | 2.7754 | 4.56 | 0.40 | 2.03 | 2,821,469 | -0.8565 | -30.86% |
| 5 Years | 3.40 | 5.49 | 0.40 | 2.04 | 2,146,906 | -1.48 | -43.56% |
Citius Pharmaceuticals Description
| Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments. |
